Literature DB >> 6801184

Murine interstitial nephritis. I. Analysis of disease susceptibility and its relationship of pleiomorphic gene products defining both immune-response genes and a restrictive requirement for cytotoxic T cells at H-2K.

E G Neilson, S M Phillips.   

Abstract

Anti-tubular basement membrance (alpha TBM) disease-producing interstitial nephritis in mice is not dependent on the generation of alpha TBM antibodies. Susceptibility seems to be defined by very private specificities in H-2K. These specificities are pleiomorphic, providing both immune-response genes and identity restrictions for cytotoxic effector functions expressed by a Thy-1.2+, Lyt-2,3+ T cell. These studies establish a role for T cells in the pathogenesis in interstitial nephritis as well as providing further evidence for the role of H-2K in the expression of an autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801184      PMCID: PMC2186652          DOI: 10.1084/jem.155.4.1075

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Role of sensitized cells in antitubular basement membrane interstitial nephritis.

Authors:  D H Lehman; C B Wilson
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

2.  Immunopathologic study of an autoimmune tubular and interstitial renal disease in brown Norway rats.

Authors:  T Sugisaki; J Klassen; F Milgrom; G A Andres; R T McCluskey
Journal:  Lab Invest       Date:  1973-06       Impact factor: 5.662

3.  Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes.

Authors:  G M Shearer
Journal:  Eur J Immunol       Date:  1974-08       Impact factor: 5.532

4.  Interstitial nephritis in rats immunized with heterologous tubular basement membrane.

Authors:  D H Lehman; C B Wilson; F J Dixon
Journal:  Kidney Int       Date:  1974-03       Impact factor: 10.612

5.  Renal tubular disease and autoantibodies against tubular basement membrane induced in guinea pigs.

Authors:  R W Steblay; U Rudofsky
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

6.  Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility.

Authors:  C C Bernard
Journal:  J Immunogenet       Date:  1976-08

7.  The role of macrophages in the generation of T-helper cells. I. The requirement for macrophages in helper cell induction and characteristics of the macrophage-T cell interaction.

Authors:  P Erb; M Feldmann
Journal:  Cell Immunol       Date:  1975-10       Impact factor: 4.868

8.  Studies on the pathogenesis of experimental anti-tubular basement membrane nephritis in the guinea pig.

Authors:  M J Van Zwieten; A K Bhan; R T McCluskey; A B Collins
Journal:  Am J Pathol       Date:  1976-06       Impact factor: 4.307

9.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes.

Authors:  A S Rosenthal; E M Shevach
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  18 in total

1.  Tubular antigen-binding proteins repress transcription of type IV collagen in the autoimmune target epithelium of experimental interstitial nephritis.

Authors:  T P Haverty; C J Kelly; J R Hoyer; R Alvarez; E G Neilson
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

Review 2.  Contrasuppression in autoimmunity.

Authors:  C J Kelly; E G Neilson
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

3.  Polymorphism of genes involved in anti-tubular basement membrane disease in rats.

Authors:  E G Neilson; D L Gasser; E McCafferty; B Zakheim; S M Phillips
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

4.  Molecular characterization of a major nephritogenic domain in the autoantigen of anti-tubular basement membrane disease.

Authors:  E G Neilson; M J Sun; C J Kelly; W H Hines; T P Haverty; M D Clayman; N E Cooke
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

5.  Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor.

Authors:  C M Meyers; C J Kelly
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Inhibitory role of dietary protein restriction on the development and expression of immune-mediated antitubular basement membrane-induced tubulointerstitial nephritis in rats.

Authors:  D Agus; R Mann; D Cohn; L Michaud; C Kelly; M Clayman; E G Neilson
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

7.  Molecular analysis of the helper T cell response in murine interstitial nephritis. T cells recognizing an immunodominant epitope use multiple T cell receptor V beta genes with similarities across CDR3.

Authors:  P S Heeger; W E Smoyer; T Saad; S Albert; C J Kelly; E G Neilson
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Effector mechanisms in organ-specific autoimmunity. I. Characterization of a CD8+ T cell line that mediates murine interstitial nephritis.

Authors:  C M Meyers; C J Kelly
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

9.  Isolation of the target antigen of human anti-tubular basement membrane antibody-associated interstitial nephritis.

Authors:  M D Clayman; L Michaud; J Brentjens; G A Andres; N A Kefalides; E G Neilson
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  Isolation and characterization of the tubular basement membrane antigen associated with human tubulo-interstitial nephritis.

Authors:  K Yoshioka; S Hino; T Takemura; H Miyasato; E Honda; S Maki
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.